CD19 and neoplasm: Based on the measurement of tumor size on day 18 post-Raji injection as shown in Fig 6A, tumor size in the anti-CD19 CAR CIKZ group was significantly smaller than that in the mGFP CAR CIKZ group (p < 0.05) and PBS group (p < 0.001).